台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    24.05
  • 漲跌
    ▲0.05
  • 漲幅
    +0.21%
  • 成交量
    209
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/17 ~ 2024/05/01     後一日»

券商獲利排行 - 2024/04/17 ~ 2024/05/01

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.78%43.11.142-224322724.223.924.224.1
  0.99%17017-7017124.324.324.324.1
  0.82%16.711.65.1-30548424.12424.224.1
  0.70%10.6010.6-6206224.2024.224.1
  1.11%8.408.43232023.823.8024.1
  0.78%7.67.30.2-1394024.224.124.324.1
  1.02%5.505.5-2202224.3024.324.1
  1.32%5.14.90.1-2141623.923.824.124.1
  1.01%4.904.9-2002024.3024.324.1
  1.11%4.913.9-1351824.324.224.324.1
  0.87%4.204.2-2002024.3024.324.1
  0.63%3.50.53-2212324.223.724.224.1
  0.69%3.403.4-2002024.2024.224.1
  1.39%3.32.11.2410523.923.824.224.1
  0.62%303-1902024.224.224.224.1
  0.62%303-2002024.2024.224.1
  2.29%2.82.800552423.824.324.1
  0.53%2.702.7-2102124.2024.224.1
  1.03%2.502.5-1001024.3024.324.1
  0.30%2.102.1-2802924.124.124.124.1
  0.82%202-1001024.3024.324.1
  1.06%1.81.20.6-25724.224.124.324.1
  1.42%1.71.20.53522423.924.524.1
  0.94%1.601.6-70724.3024.324.1
  0.92%1.60.70.9-52724.223.924.224.1
  1.28%1.61.30.3-14524.22424.324.1
  0.64%1.51.9-0.4310724.324.224.524.1
  1.25%1.51.5005524.123.924.224.1
  1.03%1.501.5-60624.3024.324.1
  0.22%1.40.11.3-2332724.124.124.124.1
  0.72%1.40.60.8-44824.224.124.324.1
  1.39%1.410.3-13424.22424.424.1
  1.33%1.301.3-40424.4024.424.1
  1.03%1.301.3-50524.3024.324.1
  0.74%1.201.3-51724.324.324.324.1
  0.44%1.21.100111024.12424.124.1
  1.14%1.10.60.5-22424.22424.324.1
  1.16%1.101.144023.823.8024.1
  1.52%1.10.70.41312423.924.524.1
  0.72%1.101.1-60624.2024.224.1
  2.17%10.70.3-11224.123.624.324.1
  0.41%101-1001024.2024.224.1
  0.82%101-50524.3024.324.1
  1.04%10.40.63412423.924.324.1
  1.03%101-40424.3024.324.1
  0.20%101-2002024.1024.124.1
  0.66%0.900.966023.923.9024.1
  1.23%0.90.10.8-11324.424.324.524.1
  0.74%0.9-0.11-41524.324.424.324.1
  0.82%0.800.8-40424.3024.324.1

券商虧損排行 - 2024/04/17 ~ 2024/05/01

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.62%-310-31208208024.224.2024.1
  -0.35%-13.9-14.50.5-5910516424.124.224.124.1
  -0.82%-12.6-4.9-7.641632224.224.22424.1
  -0.64%-11.9-0.2-11.767771024.224.224.224.1
  -1.11%-11.10-114041124.324.324.324.1
  -0.82%-6.8-4.2-2.57342624.324.424.224.1
  -1.16%-6.50-6.52323024.324.3024.1
  -1.73%-6.10-6.1-1501523.6023.624.1
  -1.92%-6-5.2-0.8-310132424.323.824.1
  -0.80%-5.9-0.4-5.42530524.324.324.224.1
  -0.53%-5.60.5-6.14043324.224.224.424.1
  -1.47%-5.40-5.41515024.424.4024.1
  -0.72%-4.90-4.92728024.224.224.124.1
  -0.40%-4.4-5.30.9-20264624.224.324.124.1
  -0.28%-4.1-3.4-0.74595424.124.224.124.1
  -1.03%-3.50-3.51414024.324.3024.1
  -1.03%-3.30-3.31313024.324.3024.1
  -1.14%-3.20-3.2-1201223.8023.824.1
  -0.47%-3.20-3.22828024.224.2024.1
  -0.45%-2.90-2.92626024.224.2024.1
  -0.79%-2.5-0.1-2.41213124.324.324.224.1
  -0.82%-2.40-2.41212024.324.3024.1
  -0.93%-2.30-2.31010024.324.3024.1
  -0.50%-2.2-1-1.26181224.224.324.224.1
  -0.24%-2.10-2.13737024.124.1024.1
  -0.64%-20-21313024.224.2024.1
  -1.64%-20-255024.524.5024.1
  -0.75%-2-1.6-0.461152424.123.824.1
  -0.76%-1.9-0.4-1.4710324.224.324.124.1
  -0.86%-1.7-1.2-0.438524.124.22424.1
  -0.84%-1.60-1.6-80823.9023.924.1
  -1.28%-1.6-0.8-0.725324.324.424.124.1
  -0.52%-1.5-0.3-1.2812424.224.224.124.1
  -0.55%-1.40-1.4-1101123.9023.924.1
  -0.97%-1.4-0.8-0.646224.124.223.824.1
  -1.45%-1.4-0.9-0.524224.224.323.924.1
  -0.82%-1.40-1.477024.324.224.524.1
  -1.08%-1.3-0.7-0.6-3252424.223.924.1
  -0.62%-1.20-1.288024.224.2024.1
  -0.91%-1.10-1.155024.324.3024.1
  -0.54%-1-1.20.1-35824.224.324.124.1
  -0.69%-10-156024.224.224.124.1
  -0.82%-10-145024.224.324.224.1
  -0.82%-10-155024.324.3024.1
  -0.42%-10-1-901024242424.1
  -0.82%-10-155024.224.2024.1
  -0.67%-10-1-41623.823.823.924.1
  -0.79%-1-0.5-0.535224.124.22424.1
  -1.94%-10-112024.524.524.124.1
  -0.53%-0.90-0.977024.224.2024.1
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章